Well-ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system

被引:345
作者
Xia, W
Chang, J
机构
[1] Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China
关键词
mesoporous; bioactive glass; controlled release; gentamicin; drug delivery;
D O I
10.1016/j.jconrel.2005.11.002
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The local drug release system is considered to be an alternative to treat the bone infection. In this paper, well-ordered mesoporous bioactive glasses (MBG) with high specific surface area have been synthesized in aqueous solution by a two-step acid-catalyzed self-assembly process combined with hydrothermal treatment. Gentamicin was encapsulated into the MBG by adsorption method and in vitro release of gentamicin from MBG was performed in distilled water and modified simulated body fluid (SBF), respectively. The results showed that the amount of drug loading of MBG was three times more than that of conventional sol-gel 58S. The outcomes of drug release in distilled water and in SBF showed that M58S effectively decreased the initial burst. During the release period, gentamicin was released from the M58S at a much lower release rate as compared to that from 58S after soaking in distilled water and SBF. Furthermore, the drug release was sensitive to the pH and ionic concentration of the release medium suggesting possible controls of the release rate. In addition, in contrast to conventional sol-gel 58S, M58S had higher ability to induce hydroxyapatite (HAp) formation. Therefore, well-ordered mesoporous bioactive glasses might be used as a bioactive drug release system for preparation of bone implant materials. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 26 条
  • [1] Bioactivity in glass/PMMA composites used as drug delivery system
    Arcos, D
    Ragel, CV
    Vallet-Regí, M
    [J]. BIOMATERIALS, 2001, 22 (07) : 701 - 708
  • [2] BUCHOLZ HW, 1989, ORTHOPAEDIC INFECT, P477
  • [3] Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?
    Ciampolini, J
    Harding, KG
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (898) : 479 - 483
  • [4] Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery
    Doadrio, AL
    Sousa, EMB
    Doadrio, JC
    Pariente, JP
    Izquierdo-Barba, I
    Vallet-Regí, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 97 (01) : 125 - 132
  • [5] Hench L.L., 1971, Journal of Biomedical Materials Research Symposium, V36, P117, DOI DOI 10.1002/JBM.820050611
  • [6] BIOCERAMICS - FROM CONCEPT TO CLINIC
    HENCH, LL
    [J]. JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 1991, 74 (07) : 1487 - 1510
  • [7] Bioactivity in ordered mesoporous materials
    Horcajada, P
    Rámila, A
    Boulahya, K
    González-Calbet, J
    Vallet-Regí, M
    [J]. SOLID STATE SCIENCES, 2004, 6 (11) : 1295 - 1300
  • [8] SOLUTIONS ABLE TO REPRODUCE INVIVO SURFACE-STRUCTURE CHANGES IN BIOACTIVE GLASS-CERAMIC A-W3
    KOKUBO, T
    KUSHITANI, H
    SAKKA, S
    KITSUGI, T
    YAMAMURO, T
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (06): : 721 - 734
  • [9] MCM-41 organic modification as drug delivery rate regulator
    Muñoz, B
    Rámila, A
    Pérez-Pariente, J
    Díaz, I
    Vallet-Regí, M
    [J]. CHEMISTRY OF MATERIALS, 2003, 15 (02) : 500 - 503
  • [10] Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO